Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Aug 2011| Analyst - John Bergin| Code - BIO049D
Market Research Report Single User License: $2,750 Member Price: FREE

Report Highlights

The global value of the overall biochips market, by end use was $3.5 billion in the year 2010. The size of the biochips market will increase from $3.9 billion in 2011 to nearly $9.6 billion by 2016, a compound annual growth rate (CAGR) of 19.5%.

Report Scope

The study scope includes the major biochip platforms that are likely to become commercialized within the next 5 years.  Each technology is analyzed to determine its market status, impact on future market segments, and forecasted growth from 2011 through 2016.  Technology status and market driving forces are discussed.  Factors that influence the market are discussed, including growth driving forces; industry alliances and acquisitions; applications in diagnostics and drug discovery; customer needs; and competitive trends. 

BCC also examines specific market segments, including digital polymerase chain reaction (PCR); China biochips; and peptide microarrays.  We also examine patent strategies within the industry.  140 companies are profiled in the report. 

Analyst Credentials

The author, John Bergin, has written previous BCC biotechnology reports titled Epigenomics:  Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets:  Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Markets; Biologic Imaging Reagents: Future Technologies and Markets; and Synthetic Biology.  Mr. Bergin has held business development, sales, and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with an emerging nanotechnology company.  Mr. Bergin holds the following degrees:  BS Chemistry, MS Biotechnology, and Masters of Business Administration.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
Published - Jan-2010| Analyst - John Bergin| Code - BIO049C

Report Highlights

  • The total market for biochips was $2.4 billion in 2008 which increased to $2.6 billion in 2009. This is expected to grow at compound annual growth rate (CAGR) of 17.7% to reach $5.9 billion by 2014
  • The DNA microarrays market was nearly $1.2 billion in 2008; this further increased to $1.3 billion in 2009, this projected to reach $2.7 billion in 2014, for a 5-year CAGR of 15.2%.
  • Sales in the LOAC market amounted to $755 million in 2008 which increased to $817 million in 2009. This is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 20.9%.
Published - Sep-2007| Analyst - John Bergin| Code - BIO049B

Report Highlights

  • The global market for biochips increased from $1,637.5 million in 2006 to an estimated $2,115.6 million by the end of 2008. It should reach $3,840.7 million in 2013, a compound annual growth rate (CAGR) of 12.7%.
  • DNA microarrays dominate the market today, expected to be worth $947.3 million in 2007, followed by lab-on-a-chip (LOAC), expected to be worth $625.8 million in 2007.
  • The largest market segment for biochips is in drug discovery and development.
Published - Jan-2004| Analyst - Sam Brauer| Code - BIO049A

Report Highlights

  • The total market for DNA microarrays and materials totaled $544.4 million in 2002. Rising at an AAGR (average annual growth rate) of 13.4%, this market is expected to just exceed $1 billion in 2007.
  • Microarrays themselves make up the bulk of the market and sales are expected to rise at an AAGR of 11.7% through 2007 to reach $744 million.
  • Materials sales will rise faster due to increasing complexity, reaching $275 million in 2007 at an AAGR of 18.8%.
  • Although DNA microarrays are entering a period of more modest growth (growth was at 30%/year just a few years ago), there are some dramatic changes taking place in the types of microarrays being produced.

RELATED REPORTS
Share This Report